Table 2.

Clinical information of the three pre-processed cohorts.

Characteristic		Training Set (n = 318)	Entire Set (n = 424)	p value	GSE39582 (n = 536)	GSE17536 (n = 144)
Age (years)	≤60	96	131	0.899	143	46
	>60	222	293		393	98
Survival Status	Living	237	310	0.727	389	108
	Dead	81	114		147	36
Gender	female	145	195	0.974	240	69
	male	173	229		296	75
pathologic_T	T1	6	10	0.907	12	–
	T2	59	73		47	–
	T3	221	293		349	–
	T4	32	47		105	–
pathologic_N	N0	184	248	0.905	293	–
	N1	80	101		127
	N2/N3	54	75		92	–
pathologic_M	M0	238	314	0.857	485	–
	M 1/M X	76	105		32	–
Tumor Stage	Stage I	53	70	0.994	37	24
	Stage II	119	162		260	55
	Stage III	91	122		205	55
	Stage IV	46	59		30	10
Lymphatic invasion	Yes	118	147	0.642	–	–
	No	173	235		–	–
Venous invasion	Yes	67	88	1	–	–
	No	214	279		–	–